Aktie 000790 CHENGDU HUASUN TECHNOLOGY GROUP INC. , LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Chengdu huasun technology group Inc. , LTD.

Aktien

000790

CNE0000001H5

000790

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 27.06.2024 		% 5 Tage % 1. Jan.
3.43 CNY -1.72% Intraday Chart für Chengdu huasun technology group Inc. , LTD. -1.72% -32.21%
03.05. Huasun Technology will 3,8 Millionen zurückgekaufte Aktien annullieren MT
29.04. Chengdu huasun technology group Inc. , LTD. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Chengdu huasun technology group Inc. , LTD. Approves 2023 Profit Distribution Plan
Huasun Technology to Cancel 3.8 Million Repurchased Shares
Chengdu Huasun Technology Group Inc. , Ltd. Announces Cash Profit Distribution Proposal for 2023
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the Full Year Ended December 31, 2023
Chengdu Huasun Technology to Construct Drug Ingredient Plant for 480 Million Yuan
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the Nine Months Ended September 30, 2023
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the Half Year Ended June 30, 2023
Chengdu Huasun Technology to Buy 51% of Local Peer for 51 Million Yuan; Shares Jump 3%
Chengdu huasun technology group Inc. , LTD. singed a Share Transfer Agreement to acquire a 51% stake in Tibet Kangyu Pharmaceutical Co., Ltd. from Tibet Wan?an Drug Information Consulting Co., Ltd. for CNY 51 million.
Chengdu Huasun Technology Group Inc. , Ltd. Elects Chen Xudong and Zhu Chaoxi as Independent Directors; and Zhu Ying as Non-Employee Supervisor
Chengdu huasun technology group Inc. , LTD. agreed to acquire Sichuan Bohaoda Biotechnology Co., Ltd. from Sichuan Yuanhong Biotechnology Co., Ltd. and Chengdu Bohaoda Biotechnology Co., Ltd for CNY 1 billion.
Chengdu huasun technology group Inc. , LTD. announced that it expects to receive funding from Chengdu Yuanhong Biological Technology Co., Ltd., and other investors
Chengdu Huasun Technology Group Inc. , Ltd. Announces Final Dividend on Share A for 2022, Payable on June 13, 2023
Chengdu huasun technology group Inc. , LTD. Approves Profit Distribution Proposal for 2022
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023
Chengdu Huasun Technology Group Inc., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Chengdu Huasun Technology to Invest $28 Million in Pharmaceutical Firm
Chengdu Huasun Technology Group Inc., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Chengdu Huasun Technology Group Inc., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on July 14, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 000790 Aktie
  4. Nachrichten Chengdu huasun technology group Inc. , LTD.
  5. Andere Sprachen